Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm

por Issa, Ghayas C., DiNardo, Courtney D.
Publicado en Blood Cancer J (2021)

Novel agents in Waldenström macroglobulinemia

por Issa, Ghayas C, Ghobrial, Irene M, Roccaro, Aldo M
Publicado 2011

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

por Zarka, Jabra, Short, Nicholas J., Kanagal-Shamanna, Rashmi, Issa, Ghayas C.
Publicado en Genes (Basel) (2020)

Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology

por Sacco, Antonio, Issa, Ghayas C, Zhang, Yong, Liu, Yang, Maiso, Patricia, Ghobrial, Irene M, Roccaro, Aldo M
Publicado 2010

Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

por Short, Nicholas J., Jabbour, Elias, Sasaki, Koji, Patel, Keyur, O’Brien, Susan M., Cortes, Jorge E., Garris, Rebecca, Issa, Ghayas C., Garcia-Manero, Guillermo, Luthra, Rajyalakshmi, Thomas, Deborah, Kantarjian, Hagop, Ravandi, Farhad
Publicado en Blood (2016)

NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated AML

por Abbas, Hussein A., Ravandi, Farhad, Loghavi, Sanam, Patel, Keyur P., Borthakur, Gautam, Kadia, Tapan M., Jabbour, Elias, Takahashi, Koichi, Cortes, Jorge, Issa, Ghayas C., Konopleva, Marina, Kantarjian, Hagop M., Short, Nicholas J.
Publicado en Am J Hematol (2019)

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series

por Alotaibi, Ahmad S., Yilmaz, Musa, Loghavi, Sanam, DiNardo, Courtney, Borthakur, Gautam, Kadia, Tapan M., Thakral, Beenu, Pemmaraju, Naveen, Issa, Ghayas C., Konopleva, Marina, Short, Nicholas J., Patel, Keyur, Tang, Guilin, Ravandi, Farhad, Daver, Naval
Publicado en Front Oncol (2020)

Hyper-CVAD + ponatinib vs. hyper-CVAD + dasatinib as frontline therapy for Ph-positive ALL: a propensity score analysis

por Sasaki, Koji, Jabbour, Elias, Ravandi, Farhad, Short, Nicholas J., Thomas, Deborah, Garcia-Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Issa, Ghayas C., Jeanis, Vicki, Moore, Gal, Garris, Rebecca, Pemmaraju, Naveen, Cortes, Jorge E., O'Brien, Susan, Kantarjian, Hagop
Publicado en Cancer (2016)

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

por Chamoun, Kamal, Kantarjian, Hagop, Atallah, Rami, Gonzalez, Graciela Nogueras, Issa, Ghayas C., Rios, Mary Beth, Garcia-Manero, Guillermo, Borthakur, Gautam, Ravandi, Farhad, Jain, Nitin, Daver, Naval, Konopleva, Marina, DiNardo, Courtney D., Kadia, Tapan, Pemmaraju, Naveen, Jabbour, Elias, Cortes, Jorge
Publicado en J Hematol Oncol (2019)

Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid...

por Abou Dalle, Iman, Ghorab, Ahmad, Patel, Keyur, Wang, Xuemei, Hwang, Hyunsoo, Cortes, Jorge, Issa, Ghayas C., Yalniz, Fevzi, Sasaki, Koji, Chihara, Dai, Price, Allyson, Kadia, Tapan, Pemmaraju, Naveen, Daver, Naval, DiNardo, Courtney, Ravandi, Farhad, Kantarjian, Hagop M., Borthakur, Gautam
Publicado en Blood Cancer J (2020)

Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment

por Issa, Ghayas C., Kantarjian, Hagop M., Gonzalez, Graciela Nogueras, Borthakur, Gautam, Tang, Guilin, Wierda, William, Sasaki, Koji, Short, Nicholas J., Ravandi, Farhad, Kadia, Tapan, Patel, Keyur, Luthra, Raja, Ferrajoli, Alessandra, Garcia-Manero, Guillermo, Rios, Mary Beth, Dellasala, Sara, Jabbour, Elias, Cortes, Jorge E.
Publicado en Blood (2017)

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab vs. Standard Intensive Chemotherapy (hyper-CVAD) as Frontline The...

por Jabbour, Elias, Sasaki, Koji, Ravandi, Farhad, Short, Nicholas J., Garcia-Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Cortes, Jorge, Issa, Ghayas C., Jacob, Jovitta, Kwari, Monica, Thompson, Philip, Garris, Rebecca, Pemmaraju, Naveen, Yilmaz, Musa, O’Brien, Susan, Kantarjian, Hagop
Publicado en Cancer (2019)

Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype

por Samra, Bachar, Richard-Carpentier, Guillaume, Kadia, Tapan M., Ravandi, Farhad, Daver, Naval, DiNardo, Courtney D., Issa, Ghayas C., Bose, Prithviraj, Konopleva, Marina Y., Yilmaz, Musa, Ohanian, Maro, Borthakur, Gautam, Garcia-Manero, Guillermo, Pierce, Sherry, Cortes, Jorge E., Kantarjian, Hagop, Short, Nicholas J.
Publicado en Blood Cancer J (2020)

Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML

por Short, Nicholas J., Rafei, Hind, Daver, Naval, Hwang, Hyunsoo, Ning, Jing, Jorgensen, Jeffrey L., Kadia, Tapan M., DiNardo, Courtney D., Wang, Sa A., Jabbour, Elias, Popat, Uday, Oran, Betul, Cortes, Jorge, Konopleva, Marina, Yilmaz, Musa, Issa, Ghayas C., Kantarjian, Hagop, Ravandi, Farhad
Publicado en Blood Adv (2020)

Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia

por Short, Nicholas J., Montalban-Bravo, Guillermo, Hwang, Hyunsoo, Ning, Jing, Franquiz, Miguel J., Kanagal-Shamanna, Rashmi, Patel, Keyur P., DiNardo, Courtney D., Ravandi, Farhad, Garcia-Manero, Guillermo, Takahashi, Koichi, Konopleva, Marina, Daver, Naval, Issa, Ghayas C., Andreeff, Michael, Kantarjian, Hagop, Kadia, Tapan M.
Publicado en Blood Adv (2020)

Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative ALL

por Short, Nicholas J., Kantarjian, Hagop, Sasaki, Koji, Cortes, Jorge E., Ravandi, Farhad, Thomas, Deborah, Garcia-Manero, Guillermo, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, Issa, Ghayas C., Konopleva, Marina, Kadia, Tapan M., Bueso-Ramos, Carlos, Khoury, Joseph D., Jain, Nitin, O’Brien, Susan M., Jabbour, Elias
Publicado en Cancer (2016)

Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia

por Short, Nicholas J., Patel, Keyur P., Albitar, Maher, Franquiz, Miguel, Luthra, Rajyalakshmi, Kanagal-Shamanna, Rashmi, Wang, Feng, Assi, Rita, Montalban-Bravo, Guillermo, Matthews, Jairo, Ma, Wanlong, Loghavi, Sanam, Takahashi, Koichi, Issa, Ghayas C., Kornblau, Steven M., Jabbour, Elias, Garcia-Manero, Guillermo, Kantarjian, Hagop M., Estrov, Zeev, Ravandi, Farhad
Publicado en Blood Adv (2020)

Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL

por Short, Nicholas J., Kantarjian, Hagop, Kanagal-Shamanna, Rashmi, Sasaki, Koji, Ravandi, Farhad, Cortes, Jorge, Konopleva, Marina, Issa, Ghayas C., Kornblau, Steven M., Garcia-Manero, Guillermo, Garris, Rebecca, Higgins, Jake, Pratt, Gabriel, Williams, Lindsey N., Valentine, Charles C., Rivera, Victor M., Pritchard, Justin, Salk, Jesse J., Radich, Jerald, Jabbour, Elias
Publicado en Blood Cancer J (2020)

Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative ALL in the era of MRD

por Issa, Ghayas C., Kantarjian, Hagop, Yin, C. Cameron, Qiao, Wei, Ravandi, Farhad, Thomas, Deborah, Short, Nicholas J., Sasaki, Koji, Garcia-Manero, Guillermo, Kadia, Tapan M., Cortes, Jorge E., Daver, Naval, Borthakur, Gautam, Jain, Nitin, Konopleva, Marina, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, O'Brien, Susan M., Jabbour, Elias
Publicado en Cancer (2016)

Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase...

por Short, Nicholas J., Kantarjian, Hagop M., Sasaki, Koji, Ravandi, Farhad, Ko, Heidi, Yin, C. Cameron, Garcia-Manero, Guillermo, Cortes, Jorge E., Garris, Rebecca, O'Brien, Susan M., Patel, Keyur, Khouri, Maria, Thomas, Deborah, Jain, Nitin, Kadia, Tapan M., Daver, Naval, Benton, Christopher B., Issa, Ghayas C., Konopleva, Marina, Jabbour, Elias
Publicado en Am J Hematol (2017)